BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+11.6%
5Y CAGR+7.1%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+11.6%/yr
vs +4.6%/yr prior
5Y CAGR
+7.1%/yr
Recent acceleration
Acceleration
+6.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
8 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$2.69B+13.4%
2024$2.37B+6.1%
2023$2.23B+15.4%
2022$1.94B+0.3%
2021$1.93B+1.3%
2020$1.90B+5.5%
2019$1.80B+11.7%
2018$1.61B+21.6%
2017$1.33B-30.8%
2016$1.92B-